Home Cart Sign in  
Chemical Structure| 2316817-88-4 Chemical Structure| 2316817-88-4

Structure of CB-6644
CAS No.: 2316817-88-4

Chemical Structure| 2316817-88-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CB-6644 is a novel drug exhibiting potent inhibition of specific targets, with potential applications in the treatment of metabolic diseases and cancer.

Synonyms: CB-6644

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CB-6644

CAS No. :2316817-88-4
Formula : C29H34ClFN4O5
M.W : 573.06
SMILES Code : O=C1C(NC(CC(C)(CNC(C2=C(OCC)C=C(F)C(Cl)=C2)=O)C)=O)=C(COC)N3CCCC4=CC=CC=C4N31
Synonyms :
CB-6644
MDL No. :MFCD32689451

Safety of CB-6644

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 cells 0.1 μM 48 h CB6644 preferentially inhibited the growth of YTHDF1-overexpressing HCT116 cells with an IC50 of 1.3 µmol/L, compared to 2.9 µmol/L for control cells. Cancer Res. 2024 Sep 4;84(17):2856-2872
DLD1 cells 0.5 µM 48 h CB6644 preferentially inhibited the growth of YTHDF1-overexpressing DLD1 cells with an IC50 of 1.3 µmol/L, compared to 5.0 µmol/L for control cells. Cancer Res. 2024 Sep 4;84(17):2856-2872
HS-5 200 nM 72 h To compare the sensitivity of CB-6644 between normal bone marrow stromal cells and MM cells, results showed HS-5 was less sensitive to CB-6644 Int J Mol Sci. 2024 Aug 20;25(16):9022
RPMI 8226 60 nM 72 h To determine IC50 and evaluate the effect of CB-6644 on MM cell growth, results showed CB-6644 significantly inhibited RPMI 8226 cell growth and induced apoptosis Int J Mol Sci. 2024 Aug 20;25(16):9022
MM.1S 120 nM 72 h To determine IC50 and evaluate the effect of CB-6644 on MM cell growth, results showed CB-6644 significantly inhibited MM.1S cell growth and induced apoptosis Int J Mol Sci. 2024 Aug 20;25(16):9022

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Subcutaneous xenograft model Intratumoral injection 25 mg/kg Twice a week for 20 days CB6644 significantly inhibited the growth of YTHDF1-overexpressing DLD1 and HCT116 xenografts, but had no significant effect on control xenografts. Cancer Res. 2024 Sep 4;84(17):2856-2872

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.75mL

0.35mL

0.17mL

8.73mL

1.75mL

0.87mL

17.45mL

3.49mL

1.75mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records